Harrow Health, 11875 Stock Today
| HROWM Stock | 26.24 0.14 0.54% |
Performance7 of 100
| Odds Of DistressLess than 7
|
Harrow Health, is selling at 26.24 as of the 1st of December 2024; that is 0.54% up since the beginning of the trading day. The stock's lowest day price was 26.1. Harrow Health, has only a 7 % chance of going through financial distress over the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Harrow Health, 11875 are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of September 2024 and ending today, the 1st of December 2024. Click here to learn more.
IPO Date 21st of December 2022 |
Harrow Health, is entity of United States. It is traded as Stock on NASDAQ exchange. More on Harrow Health, 11875
Moving together with Harrow Stock
Moving against Harrow Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Harrow Stock Highlights
| Business Concentration | Pharmaceutical Products, Drug Manufacturers - Specialty & Generic, Healthcare, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||
Harrow Health, 11875 (HROWM) is traded on NASDAQ Exchange in USA. It is located in null . Harrow Health, is listed under Pharmaceutical Products category by Fama And French industry classification. The company classifies itself under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry.
Check Harrow Health, Probability Of Bankruptcy
Harrow Health, Historical Income Statement
Harrow Stock Against Markets
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health, 11875. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health,. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health, 11875 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health,'s value that differs from its market value or its book value, called intrinsic value, which is Harrow Health,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health,'s market value can be influenced by many factors that don't directly affect Harrow Health,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.